MARPAI ANNOUNCES WITHDRAWAL FROM NASDAQ HEARINGS PROCESS AND WILL TRANSITION TRADING TO THE OTCQX MARKET 2024-05-24T16:09:26-04:00May 24, 2024| Read More
MARPAI TO HOST WEBCAST ON MAY 10, 2024 TO DISCUSS FIRST QUARTER 2024 FINANCIAL RESULTS 2024-05-03T13:53:49-04:00May 3, 2024| Read More
MARPAI INC. ANNOUNCES COST REDUCTION PROGRAM AND PROPERTY SUBLEASE 2024-05-02T06:09:48-04:00May 2, 2024| Read More
MARPAI INC. BOLSTERS SALES TEAM WITH TWO WORLD-CLASS EXECUTIVES 2024-04-24T11:08:38-04:00April 24, 2024| Read More
MARPAI INC. ANNOUNCES SALE OF $11.83 MILLION CONVERTIBLE NOTES 2024-04-16T12:08:50-04:00April 16, 2024| Read More
MARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS 2024-03-26T16:09:16-04:00March 26, 2024| Read More
NASDAQ PANEL GRANTS MARPAI’S REQUEST FOR EXTENSION TO COMPLY WITH CONTINUED LISTING REQUIREMENTS 2024-03-13T07:10:33-04:00March 13, 2024| Read More
MARPAI ANNOUNCES PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023 2024-03-06T07:13:24-04:00March 6, 2024| Read More
Marpai to Present at Maxim Group’s 2024 Healthcare IT Conference 2024-01-24T11:53:56-04:00January 22, 2024| Read More
Millennium Trust Acquires Maestro Health’s Consumer Directed Benefits Business 2023-12-20T12:09:22-04:00December 19, 2023| Read More
MARPAI, INC. ANNOUNCES APPOINTMENT OF TWO NEW INDEPENDENT DIRECTORS 2023-12-13T17:08:44-04:00December 13, 2023| Read More
MARPAI, INC. REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE COMPLIANCE 2023-12-06T17:09:37-04:00December 6, 2023| Read More
MARPAI, INC. CONFIRMS IT HAS FILED AN APPEAL TO NASDAQ DELISTING LETTER 2023-12-01T20:40:17-04:00December 1, 2023| Read More
MARPAI TO HOST INVESTOR WEBCAST ON NOVEMBER 29, 2023 2023-11-23T23:26:03-04:00November 23, 2023| Read More
MARPAI, INC. REPORTS THIRD QUARTER 2023 RESULTS 2023-11-13T17:12:17-04:00November 13, 2023| Read More
Marpai Names Damien Lamendola as Chief Executive Officer to Drive the Next Phase of its Growth 2023-11-06T09:11:10-04:00November 6, 2023| Read More